Health System Success

• Increased the number of patients being counseled on the purpose and use of naloxone, and either prescribed or referred them to obtain it.
• Increased the number of patients for whom the prescription drug monitoring program (PDMP) was checked prior to a new opioid prescription for chronic pain.
• Increased the number of patients who had documentation that a PDMP was checked at least quarterly.

• Increased completion of controlled substance agreements, urine drug testing, and naloxone distribution.
• Decreased the number of patients on long-term opioid therapy and high-dose opioid therapy.

• Increased the number of naloxone prescriptions.
• Reduced the duration of short-term opioid prescription.
• Since integrating the CDS tools, more than 85% of primary care clinicians now consult the PDMP before writing an opioid prescription.

New Haven, Connecticut

• Achieved a nearly 100% naloxone prescription rate for patients on daily opioid dosages ≥50 morphine milligram equivalents (MME) cared for by house staff in the primary care clinic.